News

PMB and Abrazo Health celebrate the grand opening for the first combination medical building and inpatient rehabilitation facility in Goodyear, Arizona

The 46,000 square-foot, 24-bed healthcare space provides a variety of outpatient medical services for the community as well as inpatient rehabilitation GOODYEAR, Ariz. and SAN DIEGO, Jan. 30, 2026 /PRNewswire/ — PMB, a leading healthcare […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina’s NGS ecosystem, DRAGEN software, and Illumina Connected Multiomics to rapidly transform… Click […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN?166 (ibudilast) in ALS patients

LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Intrepid Automation and Rapid Fluidics Form Strategic Partnership to Scale Microfluidic Manufacturing in the U.S.

SAN DIEGO, Jan. 29, 2026 /PRNewswire/ — Intrepid Automation, provider of industrial additive manufacturing (AM) solutions, and Rapid Fluidics, market leader in design and rapid-production services to microfluidic systems customers, today announced a strategic partnership […]

No Picture
News

Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today presented a poster […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

PMB and Sharp Rees-Stealy celebrate the grand opening of the new 75,000 square-foot medical outpatient building in Chula Vista, California

Streamlining the healthcare experience for the South Bay community: New, 75,000 square-foot, 3-story medical outpatient building provides a connected system of care SAN DIEGO, Jan. 28, 2026 /PRNewswire/ — PMB, a leading healthcare real estate […]

News

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

Safety concern warrants reevaluation of study design, including enrollment criteria Potential future trial with Auxora™ in AKI to be evaluated after data analysis LA JOLLA, Calif., Jan. 28, 2026 /PRNewswire/ — CalciMedica Inc. (“CalciMedica” or […]


ADVERTISEMENT — Advertise With Biotech Networks
News

How do nature and nurture shape our immune cells?

Highlights Salk Institute researchers analyzed immune cells from 110 people and found that genetic differences and life experiences (sickness, vaccination history, environment) impact immune cells differently. The findings help explain why people respond differently to […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

iXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases

SAN DIEGO–(BUSINESS WIRE)–iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud Biosciences, an innovator in organoid development and complex 3D biology, today announced a partnership to develop a […]

No Picture
News

Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed […]

No Picture
News

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Epirium Bio Announces Positive Type C (End-of-Phase 1) Meeting with FDA Supporting Advancement of MF-300 to a Phase 2b Clinical Trial in Sarcopenia

SAN DIEGO–(BUSINESS WIRE)–Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, immunological and fibrotic diseases, today announced outcomes from its Type C meeting with the Food and Drug Administration (FDA). Epirium has […]

No Picture
News

Sinopia Biosciences Strengthens Intellectual Property Estate With Issuance of Composition of Matter Patent

SAN DIEGO–(BUSINESS WIRE)–Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics discovered using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced the issuance of a composition of matter patent by the United […]